lung malignancy
Recently Published Documents


TOTAL DOCUMENTS

200
(FIVE YEARS 74)

H-INDEX

12
(FIVE YEARS 2)

2022 ◽  
Vol 10 ◽  
pp. 232470962110633
Author(s):  
Oluyemisi Amoda ◽  
Elmarie Alexander ◽  
Hesham Abowali ◽  
Ese Uwagbale ◽  
Mohammed Zaman

Lung masses are becoming more common, and although most are tumors, benign or malignant, some are not solid masses. Many pathologies can present as lung nodules, including lung cancers, hamartomas, lung abscesses, granulomas, and eosinophilic pneumonia, to name a few. A 40-year-old woman with a long history of smoking presented with cough and left-sided chest pain. After multiple imaging studies, she was thought to have a lung malignancy; however, multiple biopsies proved this was not the case. The histology reports of 3 to 4 biopsies at separate times indicated chronic inflammation ongoing in the lungs without any cancer cells present. She was treated for chronic eosinophilic pneumonia with a resolution of symptoms. The purpose of this case report is to discuss a case that was initially thought to be a lung mass but found to be chronic eosinophilic pneumonia manifesting as a lung mass.


2021 ◽  
Vol 8 (1) ◽  
pp. 65-70
Author(s):  
Viera Mrázová ◽  
Ján Mocák ◽  
Elena Varmusová ◽  
Denisa Kavková

The aim of this work is assessing diagnostic performance of lung tumour markers. Three clinical laboratory tests were used for indicating lung malignancy in order to verify or predict the patient’s diagnosis. The data set of 182 patients was examined and two main groups of the patient samples were created – 86 with diagnosed malignancy (confirmed by histology) and 96 with diagnosed benign tumours or tuberculosis. The following tumour markers were analyzed: carcinoembryonic antigen and cytokeratin 19 fragment, which were sampled in the pleural exudates, and the same tumour markers in serum. In addition, the patient’s age and the gender of the corresponding individual were used as further variables in the original data matrix. Three laboratory tests were used for indicating lung malignancy in order to verify or predict the patient’s diagnosis not only by using the results of the chosen individual laboratory test but also applying multivariate statistical approach, which jointly utilizes all performed tests in the form of their optimal linear combination.


2021 ◽  
Vol 429 ◽  
pp. 118341
Author(s):  
Nijanth Manohara Raj ◽  
Koh Yeow Hoay ◽  
Shahul Hameed

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A1715
Author(s):  
Saad Farooq ◽  
Ebrahim Khan ◽  
Omar Yacob ◽  
Chee Chan

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A1615
Author(s):  
Fahid Alghanim ◽  
Hatoon Abbas ◽  
William Grier ◽  
Kevin Li ◽  
Max An ◽  
...  

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A366
Author(s):  
Adithya Shetty ◽  
Arup Ganguly ◽  
Vinayak Jain
Keyword(s):  

Author(s):  
C. S. Balachandar

In patients with bronchiectasis, a high-resolution CT scan (HRCT) and its score play a significant role in identifying pathological alterations and pulmonary functional impairment. A total of 50 cases were studied. All the cases presenting with the features suggestive of bronchiectasis were screened clinically . 8 out of 50 patients underwent surgical resection of affected lobes. The rest was handled with caution. The primary condition, lung malignancy, claimed the life of one patient. CT can be used to quickly confirm suspected bronchiectasis due to its increased specificity. Confirmation by CT is useful in the management of patients with chronic cough and sputum production who are suspected of having bronchiectasis but for whom surgery is not an option due to age or poor lung function. In some cases, where surgery appears to be a viable option, unmistakable evidence of bilateral bronchiectasis on CT would rule out such treatment without the requirement for bronchography.


Sign in / Sign up

Export Citation Format

Share Document